Prof.Dr Mohsen Ibrahim article III

THE BETA BLOCKADE DILEMMA

The role of beta-adrenergic blocking drugs in the initial management of hypertensive patients has been recently challenged after the publication of the results of two large drug trials (LIFE and ASCOT) and meta-analysis (Lindholm et al.) to the extent that the recent British Hypertension Society Guidelines and the NICE Hypertension Recommendations (2006) stated that "beta-blockers (BB) are no longer preferred as routine initial therapy".

Section: 
Cardiovascular & Diabetes